ESG

The final phase of the Tour & Taxis transformation begins, promising a sustainable district with 700+ homes, affordable housing, and geothermal energy.

President Trump's 100% tariff on imported drugs aims to secure the US supply chain, but the policy's success may hinge on unproven and unverified players.

Biopharma firm GENFIT sees soaring Iqirvo sales and a cash runway past 2028, overshadowing a net loss driven by strategic, non-cash write-downs.

MFS postpones a key shareholder vote on a major municipal fund merger, offering a tender to sway investors as Aberdeen prepares to take the helm.

A new partnership aims to tackle the US energy crisis by delivering mobile natural gas to power-hungry data centers and industries the grid can't support.

Manufacturers are spending millions on ERP systems with poor results. Discover why a 'process-first' approach is becoming critical for survival and growth.

Indigenous leaders from the Prairies unite to nullify 1930s resource agreements, warning of economic instability and demanding nation-to-nation talks.

The relentless pursuit of a perfect sleep score may be the very thing ruining your rest. Experts warn of a new phenomenon called 'orthosomnia'.

Wisconsin's largest nonprofit hospice now serves the entire southern half of the state, bringing its patient-first model to four new counties.

Lucid's award-winning Gravity SUV gets a major upgrade, adding standard tech and a new Prestige Package to challenge luxury EV rivals head-on.

A major lab expansion in Massachusetts aims to slash preclinical timelines for the most promising new cancer treatments, including advanced radiotherapies.

Dxcover's new AI platform uses infrared light to detect early-stage colorectal, pancreatic, and ovarian cancers from blood with unprecedented sensitivity.

From PFAS cleanup to AI data center cooling, this Illinois firm’s rapid growth and key innovations are tackling critical industrial challenges.

As a critical FDA drug safety reporting deadline looms, a new cloud tool helps smaller biotech and pharma firms avoid costly penalties and level the field.

With a new private equity partnership, Dossier is set to expand its mission of making luxury scents accessible, scaling its retail and global footprint.

Matthew & Camila McConaughey's organic tequila brand is launching in Asia, tackling a complex market with a mix of celebrity power and strategic partnerships.

A pivotal clinical trial for PMM2-CDG, a devastating genetic disorder with no approved treatments, has completed enrollment, offering hope to thousands.

A massive 1GW+ AI data center in Texas will use innovative CO2 battery tech to create its own power, tackling grid strain and setting a new energy model.

As AI drives a data center boom, local opposition mounts. A new service aims to broker peace with community-focused, legally binding agreements.

After a year of declines, home prices are leveling off, creating a rare window of opportunity for buyers with more choice and negotiating power.